Clinical Trials · NCT01617434
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 451
- Start date
- Sep 2012
- Locations
- 86 sites, 9 countries
- Primary endpoint
- Change in Glycosylated Haemoglobin (HbA1c) From Baseline to Week 26